| |
| |
|
| Insider
Information: |
Beshar Luke M |
| Relationship: |
Director |
| City: |
East Rutherford |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
198,000 |
|
|
Indirect Shares
|
1,081 |
|
|
| Direct
Value |
$528,660 |
|
|
|
Indirect Value
|
$64,795 |
|
|
| Total
Shares |
199,081 |
|
|
| Total
Value |
$593,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cambrex Corp |
CBM |
Executive Vice President |
2007-10-10 |
0 |
2005-12-31 |
1,081 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
EVP & CFO |
2015-02-21 |
0 |
2011-01-31 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2018-11-29 |
0 |
2018-11-19 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2022-06-30 |
198,000 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
62,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,967 |
62,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,832 |
63,464 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-29 |
4 |
OE |
$4.05 |
$19,643 |
D/D |
4,850 |
64,030 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,530 |
65,061 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
66,050 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-13 |
4 |
D |
$45.88 |
$219,719 |
D/D |
(4,789) |
67,779 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,531 |
72,568 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-10-31 |
4 |
AS |
$29.00 |
$290,000 |
D/D |
(10,000) |
72,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-11-17 |
4 |
AS |
$30.01 |
$1,423,640 |
D/D |
(47,442) |
72,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-12-17 |
4 |
AS |
$35.00 |
$1,829,030 |
D/D |
(52,258) |
72,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2015-02-17 |
4 |
OE |
$8.21 |
$86,900 |
D/D |
7,422 |
75,201 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-10-27 |
4 |
AS |
$26.75 |
$819,606 |
D/D |
(30,635) |
82,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-01-08 |
4 |
OE |
$3.34 |
$105,504 |
D/D |
31,588 |
90,768 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-12-26 |
4 |
OE |
$3.34 |
$195,822 |
D/D |
37,874 |
97,054 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-05-09 |
4 |
OE |
$4.05 |
$182,858 |
D/D |
45,150 |
104,330 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-04-10 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-09-16 |
4 |
OE |
$4.05 |
$202,500 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-09-20 |
4 |
OE |
$5.71 |
$286,200 |
D/D |
50,000 |
109,180 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-08-13 |
4 |
OE |
$3.34 |
$185,915 |
D/D |
53,813 |
113,415 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2013-12-12 |
4 |
OE |
$8.21 |
$496,735 |
D/D |
60,311 |
119,491 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-11-17 |
4 |
OE |
$3.34 |
$223,564 |
D/D |
47,442 |
120,222 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
EVP & CFO |
• – – |
2014-12-17 |
4 |
OE |
$3.34 |
$373,670 |
D/D |
52,258 |
125,038 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
168,000 |
168,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2022-03-10 |
4 |
B |
$4.46 |
$44,555 |
D/D |
10,000 |
178,000 |
2.39 |
% |
|
77 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
